Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
KP.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
MF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XDK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JQ.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.502ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.285ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.582ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.580ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.306ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.280ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.329ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used